Oncimmune Holdings Plc (ONC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 05-2018 | 05-2017 | 05-2016 | 05-2015 | 05-2014 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 0 | -293 | -566 | 0 | -181 |
| Accounts receivable | -30 | 177 | -304 | 320 | 331 |
| Other Working Capital | -54 | 357 | -179 | -40 | 576 |
| Other Operating Activity | -6,017 | -4,520 | -2,130 | -1,800 | -2,875 |
| Operating Cash Flow | $-6,101 | $-4,279 | $-3,179 | $-1,520 | $-2,149 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -7 | -64 | -17 | -43 |
| Purchase Sale Intangibles | -281 | -415 | -108 | -35 | 0 |
| Other Investing Activity | 0 | 0 | 5 | 15 | 950 |
| Investing Cash Flow | $-312 | $-422 | $-167 | $-37 | $907 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 1,250 | 1,449 | 1,825 |
| Debt Repayment | -502 | -388 | -423 | -203 | -29 |
| Common Stock Issued | 14,785 | 0 | 11,448 | 0 | 4 |
| Financing Cash Flow | $14,283 | $-388 | $12,275 | $1,246 | $1,800 |
| Exchange Rate Effect | 8 | -33 | -76 | 87 | -124 |
| Beginning Cash Position | 5,075 | 10,197 | 1,344 | 1,568 | 1,134 |
| End Cash Position | 12,953 | 5,075 | 10,197 | 1,344 | 1,568 |
| Net Cash Flow | $7,870 | $-5,089 | $8,929 | $-311 | $558 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,101 | -4,279 | -3,179 | -1,520 | -2,149 |
| Capital Expenditure | -312 | -422 | -172 | -52 | -43 |
| Free Cash Flow | -6,413 | -4,701 | -3,351 | -1,572 | -2,192 |